Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_39748 | 17060 | 355.41 | Mlig455_068905 | Neo: - Age: - Region-enriched R7: 2.255/0.00030 Regeneration-downregulated BL: -3.088 Regeneration-depleted BL: -3.088 |
Mlig455_068905 {REF} {Length: 1123} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=52.4, Expect=4e-08]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1310_55834.1, RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549, RNA815_29732} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.349 | 8.547 | 0.61345 | 1.00000 | |
RegionR2 | 1.027 | 8.547 | 0.06959 | 0.32094 | |
RegionR3 | -0.578 | 8.547 | 0.30539 | 0.84613 | |
RegionR4 | -0.674 | 8.547 | 0.27668 | 0.58338 | |
RegionR5 | -1.546 | 8.547 | 0.00991 | 0.05734 | |
RegionR6 | 0.126 | 8.547 | 0.81558 | 1.00000 | |
RegionR7 | 2.255 | 8.547 | 0.00000 | 0.00030 | |
RegionR8 | -0.262 | 8.547 | 0.63570 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.456 | 8.547 | 0.56404 | 1.00000 | |
RegenerationR2 | -0.999 | 8.547 | 0.16260 | 0.59988 | |
RegenerationR3 | -0.944 | 8.547 | 0.17973 | 0.61565 | |
RegenerationR4 | -0.905 | 8.547 | 0.21061 | 0.65829 | |
RegenerationR5 | -0.726 | 8.547 | 0.30082 | 0.72800 | |
RegenerationR6 | -1.582 | 8.547 | 0.02749 | 0.20720 | |
RegenerationBL | -3.088 | 8.547 | 0.00002 | 0.00115 | Specific for BL: -3.088 |
RegenerationTP | -2.398 | 8.547 | 0.00079 | 0.04195 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_39748 | 17060 | 355.41 | Mlig455_068905 | Neo: - Age: - Region-enriched R7: 2.255/0.00030 Regeneration-downregulated BL: -3.088 Regeneration-depleted BL: -3.088 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_068905 {REF} {Length: 1123} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=52.4, Expect=4e-08]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1310_55834.1, RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549, RNA815_29732} | |
2. | MligTC455_39747 | 9244 | 192.57 | Mlig455_062337 | Neo: - |
5.626 | 0.968 | 0.978 | 0.890 | 0.909 | 0.993 | 0.888 | Mlig455_062337 {REF} {Length: 1172} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=60.1, Expect=9e-11]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_16548, RNA1509_58675} {RNA1310_55834.1, RNA1509_58675} {RNA1509_58675, RNA815_29732} | |
3. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 5.085 | 0.730 | 0.787 | 0.730 | 0.932 | 0.936 | 0.970 | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
4. | MligTC455_30487 | 7077 | 147.44 | Mlig455_046773, Mlig455_060559 | Neo: - |
4.948 | 0.827 | 0.716 | 0.738 | 0.927 | 0.969 | 0.771 | Mlig455_046773 {REF} {Length: 1094} {RNA1509_13428, RNA1509_37924, RNA1509_44808} {RNA1310_38257.2, RNA1509_13428, RNA1509_44808} {RNA1509_13428, RNA1509_44808, RNA815_6548} Mlig455_060559 {REF} {Length: 1175} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=24.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=21.4]} {Celegans: WBGene00008885, F16C3.1, [Score=53.9, Expect=8e-08]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=97.4, Expect=2e-22]} |
|
5. | MligTC455_53579 | 15576 | 324.49 | Mlig455_010515 | Neo: - Age: - Region-enriched R2: 1.446/0.00265 Regeneration-downregulated BL: -1.566 Regeneration-depleted BL: -1.566 |
4.6 | 0.790 | - | 0.925 | 0.953 | 0.965 | 0.967 | Mlig455_010515 {REF} {Length: 1448} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=80.3]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=2e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=5e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=119, Expect=7e-32]} {RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1310_24594, RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1509_1202, RNA1509_1348, RNA1509_17830, RNA815_8289} | |
6. | MligTC455_53581 | 10826 | 225.54 | Mlig455_061865 | Neo: - Age: Down-Down-Up Region-specific R2: 2.296 Region-enriched R2: 1.603/0.00040 Regeneration-downregulated BL: -1.690 Regeneration-depleted BL: -1.690 |
4.544 | 0.813 | - | 0.863 | 0.965 | 0.943 | 0.960 | Mlig455_061865 {REF} {Length: 1605} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=82.0]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=1e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=4e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=118, Expect=1e-31]} {RNA1509_1202, RNA1509_24767} {RNA1310_24594, RNA1509_24767} {RNA1509_24767, RNA815_8289} | |
7. | MligTC455_53580 | 10830 | 225.63 | Mlig455_061858 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.371 Region-specific R2: 2.295 Region-enriched R2: 1.602/0.00040 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
4.542 | 0.813 | - | 0.863 | 0.965 | 0.942 | 0.959 | Mlig455_061858 {REF} {Length: 1839} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=32.7]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [Score=77.4, Expect=9e-17]} {RNA1509_2808} {RNA1310_24594} {RNA815_8289} | |
8. | MligTC455_14684 | 7049 | 146.85 | Mlig455_051414 | Neo: - Age: - Region-specific R2: 2.287 Region-enriched R2: 1.764/0.00001 Regeneration-depleted BL: -2.197 |
PAM | 4.43 | 0.909 | 0.730 | - | 0.888 | 0.944 | 0.959 | Mlig455_051414 {REF} {Length: 1674} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=89.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=194, Expect=4e-55]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=4e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=206, Expect=3e-63]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=249, Expect=2e-79]} {RNA1509_910} {RNA1310_18216.1, RNA1509_910} {RNA1509_910, RNA815_736.1} |
9. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 4.345 | 0.744 | 0.758 | - | 0.933 | 0.935 | 0.975 | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
10. | MligTC455_30481 | 4435 | 92.4 | Mlig455_069968 | Neo: - Age: - Region-enriched R7: 1.293/0.01255 Regeneration-depleted BL: -2.525 |
4.228 | 0.807 | 0.724 | - | 0.864 | 0.962 | 0.871 | Mlig455_069968 {REF} {Length: 1076} {RNA1509_21339, RNA1509_56085} {RNA1310_38257.2, RNA1509_21339, RNA1509_56085} {RNA1509_21339, RNA1509_56085, RNA815_6548} | |
11. | MligTC455_14831 | 280 | 5.83 | Mlig455_067864 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.261/0.00352 |
SSUH2 | 4.186 | 0.718 | 0.737 | - | 0.880 | 0.985 | 0.866 | Mlig455_067864 {REF} {Length: 1575} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=6e-54]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=7e-41]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=118, Expect=1e-29]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
12. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
4.111 | 0.721 | 0.736 | - | 0.962 | 0.834 | 0.858 | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
13. | MligTC455_14683 | 2425 | 50.53 | Mlig455_039611 | Neo: - Age: Down-Up-Up |
PAM | 3.751 | 0.913 | - | - | 0.912 | 0.945 | 0.981 | Mlig455_039611 {REF} {Length: 1708} {Pfam: NHL repeat [PF01436.23, score=88.3]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=191, Expect=5e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=198, Expect=4e-56]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=2e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=204, Expect=2e-62]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=251, Expect=4e-80]} {RNA1509_910, RNA1509_9422} {RNA1310_18216.1, RNA1509_9422} {RNA1509_9422, RNA815_736.1} |
14. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 3.701 | 0.853 | - | - | 0.952 | 0.935 | 0.961 | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
15. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 3.699 | 0.849 | - | - | 0.953 | 0.938 | 0.959 | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
16. | MligTC455_48218 | 1632 | 34 | Mlig455_054782, Mlig455_054874 | Neo: - Age: Down-Down-Up Region-specific R2: 3.792 Region-enriched R2: 2.673/0.00000 Regeneration-downregulated BL: -2.255 Regeneration-depleted BL: -2.255 |
3.671 | 0.864 | - | - | 0.904 | 0.936 | 0.967 | Mlig455_054782 {REF} {Length: 1928} {RNA1509_16585} {RNA1310_35143} {RNA815_1375.1} Mlig455_054874 {REF} {Length: 2445} {RNA1509_16585} {RNA1310_35143, RNA1509_16585} {RNA1509_16585, RNA815_1375.1} |
|
17. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 3.645 | - | 0.840 | - | 0.950 | 0.907 | 0.948 | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
18. | MligTC455_47806 | 2724 | 56.76 | Mlig455_033677 | Neo: - Age: - Region-specific R2: 3.773 Region-enriched R2: 2.504/0.00005 |
3.62 | - | - | 0.804 | 0.926 | 0.973 | 0.917 | Mlig455_033677 {REF} {Length: 1836} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1310_30659.1, RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504, RNA815_13807} | |
19. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
3.614 | - | 0.845 | - | 0.953 | 0.903 | 0.913 | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
20. | MligTC455_47807 | 2664 | 55.5 | Mlig455_050143 | Neo: - Age: - Region-specific R2: 3.807 Region-enriched R2: 2.561/0.00001 |
3.611 | - | - | 0.795 | 0.922 | 0.971 | 0.923 | Mlig455_050143 {REF} {Length: 1560} {RNA1509_1605, RNA1509_28756} {RNA1310_30659.1, RNA1509_28756} {RNA1509_28756, RNA815_13807} | |
21. | MligTC455_44513 | 1822 | 37.96 | Mlig455_044390 | Neo: - Age: Down-Up-Up Region-specific R2: 2.967 Region-enriched R2: 2.054/0.00008 |
3.54 | - | - | 0.716 | 0.968 | 0.941 | 0.915 | Mlig455_044390 {REF} {Length: 727} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [Score=93.2, Expect=5e-25]} {RNA1509_30750, RNA1509_53240, RNA1509_6792} {RNA1310_36193, RNA1509_30750, RNA1509_53240, RNA1509_6792} {RNA1509_30750, RNA1509_53240, RNA1509_6792, RNA815_16957} | |
22. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 3.494 | 0.749 | - | - | 0.960 | 0.951 | 0.834 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
23. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.492 | 0.749 | - | - | 0.960 | 0.950 | 0.833 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
24. | MligTC455_16872 | 306 | 6.37 | Mlig455_006228 | Neo: - Age: - Region-specific R2: 5.842 Region-enriched R2: 4.577/0.00000 |
3.485 | 0.965 | - | - | 0.920 | 0.755 | 0.845 | Mlig455_006228 {REF} {Length: 952} {RNA1310_48111} {RNA815_24753} | |
25. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.479 | 0.877 | - | - | 0.967 | 0.822 | 0.813 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
26. | MligTC455_14685 | 3975 | 82.82 | Mlig455_051429 | Neo: - Age: - Region-specific R2: 2.895 Region-enriched R2: 2.262/0.00004 |
PAM | 3.452 | - | 0.704 | - | 0.815 | 0.962 | 0.971 | Mlig455_051429 {REF} {Length: 1911} {Pfam: NHL repeat [PF01436.23, score=59.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=119, Expect=2e-28]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=115, Expect=2e-27]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [Score=115, Expect=2e-28]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [Score=125, Expect=2e-32]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [Score=138, Expect=4e-37]} {RNA1509_910} {RNA1310_18216.1} {RNA815_736.1} |
27. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
3.45 | 0.752 | - | - | 0.960 | 0.848 | 0.890 | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
28. | MligTC455_18564 | 196 | 4.08 | Mlig455_063527 | Neo: - Age: - Region-enriched R2: 2.416/0.01839 |
PRKG2 | 3.435 | - | - | 0.708 | 0.956 | 0.908 | 0.863 | Mlig455_063527 {REF} {Length: 2971} {Pfam: Protein kinase domain [PF00069.27, score=212.4]; Cyclic nucleotide-binding domain [PF00027.31, score=135.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.7]; Kinase-like [PF14531.8, score=24.8]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=653, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=651, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=662, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=655, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=645, Expect=0.0]} {RNA1509_38353} {RNA1310_8466, RNA1509_38353} {RNA1509_38353, RNA815_6313} |
29. | MligTC455_19325 | 1452 | 30.24 | Mlig455_036471, Mlig455_056256 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.575 Region-enriched R2: 2.298/0.00464 |
3.413 | 0.838 | - | - | 0.859 | 0.738 | 0.978 | Mlig455_036471 {REF} {Length: 598} {RNA1509_40294} {RNA1310_65876} {RNA815_35457} Mlig455_056256 {REF} {Length: 599} {RNA1509_40294} {RNA1310_65876, RNA1509_40294} {RNA1509_40294, RNA815_35457} |
|
30. | MligTC455_29798 | 4280 | 89.16 | Mlig455_061171 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.579 Region-enriched R2: 6.440/0.00000 |
3.325 | 0.880 | - | - | 0.957 | 0.754 | 0.734 | Mlig455_061171 {REF} {Length: 688} {RNA1509_23190} {RNA1310_44752} {RNA815_21540} | |
31. | MligTC455_20574 | 3347 | 69.74 | Mlig455_021418 | Neo: - Age: - |
PCSK2 | 2.853 | - | - | - | 0.953 | 0.975 | 0.925 | Mlig455_021418 {REF} {Length: 1212} {Pfam: Peptidase S8 pro-domain [PF16470.7, score=47.7]} {Human: ENSG00000125851, PCSK2, proprotein convertase subtilisin/kexin type 2, [Score=53.9, Expect=2e-08]} {Mouse: ENSMUSG00000027419, Pcsk2, proprotein convertase subtilisin/kexin type 2, [Score=52.8, Expect=4e-08]} {Dmel: FBgn0023179, amon, amontillado, [Score=55.8, Expect=2e-09]} {Celegans: WBGene00001172, egl-3, Neuroendocrine convertase 2, [Score=61.2, Expect=3e-11]} {Smed: dd_Smed_v6_1566_0_1, dd_Smed_v6_1566_0_1, [Score=65.1, Expect=1e-12]} {RNA1509_15978} {RNA1310_7333.1} {RNA815_2403.2} |
32. | MligTC455_23150 | 3195 | 66.56 | Mlig455_009524, Mlig455_009530 | Neo: - Age: - Region-enriched R2: 3.504/0.00000 |
CDK16 | 2.771 | - | - | - | 0.907 | 0.963 | 0.901 | Mlig455_009524 {REF} {Length: 3287} {Pfam: Protein kinase domain [PF00069.27, score=218.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [RH, Score=463, Expect=7e-159]; ENSG00000059758, CDK17, cyclin dependent kinase 17, [RH, Score=447, Expect=2e-151]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [RH, Score=464, Expect=2e-158]; ENSMUSG00000020015, Cdk17, cyclin-dependent kinase 17, [RH, Score=449, Expect=2e-152]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=362, Expect=2e-118]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [RH, Score=417, Expect=3e-138]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [RH, Score=449, Expect=6e-151]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} Mlig455_009530 {REF} {Length: 3384} {Pfam: Protein kinase domain [PF00069.27, score=208.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.4]; Haspin like kinase domain [PF12330.10, score=17.8]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [Score=432, Expect=5e-147]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [Score=431, Expect=4e-146]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=329, Expect=9e-107]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [Score=392, Expect=2e-130]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [Score=411, Expect=6e-137]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} |
33. | MligTC455_41587 | 2912 | 60.66 | Mlig455_018983, Mlig455_055720 | Neo: - Age: Down-Down-Up Region-specific R2: 3.258 Region-enriched R2: 2.529/0.00000 Regeneration-downregulated BL: -2.793 Regeneration-depleted BL: -2.793 |
2.771 | - | - | - | 0.871 | 0.940 | 0.960 | Mlig455_018983 {REF} {Length: 871} {RNA1509_9390} {RNA1310_40276} {RNA815_19143} Mlig455_055720 {REF} {Length: 988} {RNA1509_9390} {RNA1310_40276} {RNA815_19143} |
|
34. | MligTC455_53504 | 217 | 4.51 | Mlig455_037385 | Neo: - Age: - Region-enriched R2: 3.142/0.00738 |
CSMD1 | 2.768 | - | - | - | 0.958 | 0.947 | 0.863 | Mlig455_037385 {REF} {Length: 2214} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=198.7]} {Human: ENSG00000183117, CSMD1, CUB and Sushi multiple domains 1, [Score=149, Expect=8e-37]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=136, Expect=7e-33]; ENSMUSG00000060924, Csmd1, CUB and Sushi multiple domains 1, [Score=134, Expect=5e-32]; ENSMUSG00000022311, Csmd3, CUB and Sushi multiple domains 3, [Score=133, Expect=9e-32]} {Dmel: FBgn0032797, Hasp, Hig-anchoring scaffold protein, [RH, Score=218, Expect=3e-60]} {Celegans: WBGene00002976, lev-9, [RH, Score=244, Expect=4e-72]} {Smed: dd_Smed_v6_13071_0_1, dd_Smed_v6_13071_0_1, [RH, Score=296, Expect=1e-91]} {RNA1509_55985} {RNA1310_12867.1, RNA1509_55985} {RNA1509_55985, RNA815_9157} |
35. | MligTC455_19338 | 2431 | 50.65 | Mlig455_022165 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.390 Region-specific R2: 3.133 Region-enriched R2: 2.312/0.00036 |
2.705 | - | - | - | 0.951 | 0.910 | 0.844 | Mlig455_022165 {REF} {Length: 1038} {RNA1509_18606, RNA1509_6523} {RNA1310_50737, RNA1509_18606, RNA1509_6523} {RNA1509_18606, RNA1509_6523, RNA815_26880} | |
36. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 2.705 | - | - | - | 0.950 | 0.950 | 0.805 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
37. | MligTC455_29051 | 484 | 10.08 | Mlig455_064767 | Neo: - Age: - |
TMEM30A | 2.667 | - | - | - | 0.898 | 0.790 | 0.979 | Mlig455_064767 {REF} {Length: 2581} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=265.5]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [RH, Score=234, Expect=7e-73]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [RH, Score=241, Expect=6e-76]} {Dmel: FBgn0030752, CG9947, [RH, Score=294, Expect=8e-97]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=274, Expect=3e-89]} {RNA1509_38539, RNA1509_38955} {RNA1310_9371, RNA1509_38539, RNA1509_38955} {RNA1509_38539, RNA1509_38955, RNA815_12157} |
38. | MligTC455_53798 | 206 | 4.3 | Mlig455_000154, Mlig455_067724 | Neo: - |
PLK2 | 2.664 | - | - | - | 0.950 | 0.913 | 0.801 | Mlig455_000154 {REF} {Length: 2607} {Pfam: Protein kinase domain [PF00069.27, score=211.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=152.6]; POLO box duplicated region [PF00659.20, score=34.6]; Fungal protein kinase [PF17667.3, score=25.9]} {Human: ENSG00000145632, PLK2, polo like kinase 2, [Score=199, Expect=3e-55]; ENSG00000173846, PLK3, polo like kinase 3, [Score=192, Expect=6e-53]} {Mouse: ENSMUSG00000028680, Plk3, polo like kinase 3, [Score=204, Expect=1e-57]; ENSMUSG00000035486, Plk5, polo like kinase 5, [Score=202, Expect=5e-57]; ENSMUSG00000021701, Plk2, polo like kinase 2, [Score=199, Expect=1e-55]} {Dmel: FBgn0003124, polo, [Score=180, Expect=2e-49]} {Celegans: WBGene00004042, plk-1, Serine/threonine-protein kinase plk-1, [Score=188, Expect=5e-52]} {Smed: dd_Smed_v6_4273_0_1, dd_Smed_v6_4273_0_1, [Score=176, Expect=5e-48]} {RNA1509_59189} {RNA1310_13517} {RNA815_22257} Mlig455_067724 {REF} {Length: 2303} {Pfam: Protein kinase domain [PF00069.27, score=211.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=152.6]; POLO box duplicated region [PF00659.20, score=35.0]; Fungal protein kinase [PF17667.3, score=26.0]} {Human: ENSG00000145632, PLK2, polo like kinase 2, [Score=199, Expect=3e-55]; ENSG00000173846, PLK3, polo like kinase 3, [Score=197, Expect=5e-55]} {Mouse: ENSMUSG00000028680, Plk3, polo like kinase 3, [Score=204, Expect=7e-58]; ENSMUSG00000035486, Plk5, polo like kinase 5, [Score=201, Expect=1e-56]; ENSMUSG00000021701, Plk2, polo like kinase 2, [Score=199, Expect=1e-55]} {Dmel: FBgn0003124, polo, [Score=179, Expect=3e-49]} {Celegans: WBGene00004042, plk-1, Serine/threonine-protein kinase plk-1, [Score=187, Expect=9e-52]} {Smed: dd_Smed_v6_4273_0_1, dd_Smed_v6_4273_0_1, [Score=176, Expect=2e-48]} {RNA1509_59189} {RNA1310_13517, RNA1509_59189} {RNA1509_59189, RNA815_22257} |
39. | MligTC455_47783 | 422 | 8.78 | Mlig455_031120 | Neo: - |
2.653 | - | - | 0.856 | 0.845 | - | 0.952 | Mlig455_031120 {REF} {Length: 2684} {Pfam: Mab-21 protein [PF03281.16, score=59.6]} {Smed: dd_Smed_v6_43442_0_1, dd_Smed_v6_43442_0_1, [RH, Score=63.2, Expect=1e-10]} {RNA1509_15607} {RNA1310_11311} {RNA815_5452} | |
40. | MligTC455_15837 | 58 | 1.21 | Mlig455_058574 | Neo: - Age: Up-Down-Up |
PLEKHG5 | 2.643 | - | - | - | 0.966 | 0.871 | 0.806 | Mlig455_058574 {REF} {Length: 3473} {Pfam: RhoGEF domain [PF00621.22, score=89.0]; Pleckstrin homology domain [PF15405.8, score=20.1]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=191, Expect=1e-49]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=194, Expect=1e-50]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=1e-35]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=142, Expect=3e-34]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [Score=171, Expect=2e-44]} {RNA1310_47096} {RNA815_12538} |
41. | MligTC455_54204 | 344 | 7.17 | Mlig455_006398 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.351 Region-specific R2: 5.395 Region-enriched R2: 4.187/0.01201 |
MYH6 | 2.643 | - | - | - | 0.837 | 0.984 | 0.822 | Mlig455_006398 {REF} {Length: 7465} {Pfam: Myosin head (motor domain) [PF00063.23, score=927.6]; Myosin tail [PF01576.21, score=593.3]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Macoilin family [PF09726.11, score=19.0]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2074, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2064, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2019, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2012, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2006, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1991, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1973, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2073, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2039, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2016, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2014, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2008, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1978, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1993, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2702, Expect=0.0]} {RNA1509_16048, RNA1509_42411} {RNA1310_1388, RNA1509_42411} {RNA1509_42411, RNA815_129.1} |
42. | MligTC455_17586 | 579 | 12.07 | Mlig455_029070 | Neo: - Age: - Region-specific R2: 3.959 Region-enriched R2: 2.423/0.00859 Regeneration-downregulated R6: -3.050 Regeneration-depleted R6: -3.050 |
2.613 | - | - | - | 0.772 | 0.882 | 0.959 | Mlig455_029070 {REF} {Length: 859} {RNA1509_53221, RNA1509_56226} {RNA1310_52775.1, RNA1509_53221, RNA1509_56226} {RNA1509_53221, RNA1509_56226, RNA815_35656} | |
43. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 2.6 | - | - | - | 0.966 | 0.804 | 0.830 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
44. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.597 | - | - | - | 0.960 | 0.870 | 0.767 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
45. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
2.589 | - | - | - | 0.956 | 0.801 | 0.832 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
46. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 2.572 | - | - | - | 0.818 | 0.950 | 0.804 | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
47. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 2.567 | - | - | - | 0.966 | 0.771 | 0.830 | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
48. | MligTC455_54203 | 182 | 3.79 | Mlig455_061249 | Neo: - Age: - |
MYH7 | 2.557 | - | - | - | 0.787 | 0.971 | 0.799 | Mlig455_061249 {REF} {Length: 1536} {Pfam: Myosin tail [PF01576.21, score=90.6]} {Human: ENSG00000092054, MYH7, myosin heavy chain 7, [Score=200, Expect=8e-57]; ENSG00000197616, MYH6, myosin heavy chain 6, [Score=198, Expect=4e-56]; ENSG00000264424, MYH4, myosin heavy chain 4, [Score=191, Expect=2e-53]; ENSG00000125414, MYH2, myosin heavy chain 2, [Score=190, Expect=4e-53]} {Mouse: ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [Score=201, Expect=4e-57]; ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [Score=194, Expect=8e-55]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [Score=192, Expect=3e-54]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [Score=191, Expect=1e-53]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [Score=282, Expect=2e-85]} {Celegans: WBGene00003515, myo-3, Myosin-3, [Score=241, Expect=2e-71]} {Smed: dd_Smed_v6_432_0_1, dd_Smed_v6_432_0_1, [Score=285, Expect=9e-87]} {RNA1509_55838} {RNA1310_1388} {RNA815_21073} |
49. | MligTC455_26243 | 7282 | 151.7 | Mlig455_058373 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.861 Region-enriched R2: 2.532/0.00002 |
PPIB | 2.463 | 0.960 | - | 0.742 | 0.761 | - | - | Mlig455_058373 {REF} {Length: 1101} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=123.3]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=154, Expect=2e-47]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=153, Expect=4e-47]} {Dmel: FBgn0034753, CG2852, [Score=131, Expect=6e-39]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=139, Expect=4e-42]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [Score=233, Expect=6e-79]} {RNA1509_11405, RNA1509_2163} {RNA1310_10180, RNA1509_11405} {RNA1509_11405, RNA815_2338.1} |
50. | MligTC455_51696 | 624 | 12.99 | Mlig455_011356 | Neo: - Age: - |
FAM47E | 2.451 | 0.746 | - | - | 0.741 | - | 0.964 | Mlig455_011356 {REF} {Length: 2028} {Pfam: FAM47 family [PF14642.8, score=51.3]} {Human: ENSG00000189157, FAM47E, family with sequence similarity 47 member E, [RH, Score=138, Expect=9e-36]} {Mouse: ENSMUSG00000078315, Fam47c, family with sequence similarity 47, member C, [RH, Score=119, Expect=6e-29]} {Smed: dd_Smed_v6_10346_0_1, dd_Smed_v6_10346_0_1, [RH, Score=293, Expect=6e-95]} {RNA1509_41096, RNA1509_54260, RNA1509_8031} {RNA1310_12665, RNA1509_41096, RNA1509_54260} {RNA1509_41096, RNA1509_54260, RNA815_4489.1} |
51. | MligTC455_52239 | 629 | 13.1 | Mlig455_029233 | Neo: - Age: logFC(26M/2M)=-0.429 |
ABCG2 | 2.426 | - | - | - | 0.726 | 0.750 | 0.950 | Mlig455_029233 {REF} {Length: 3918} {Pfam: ABC-2 type transporter [PF01061.26, score=125.2]; ABC transporter [PF00005.29, score=73.3]; ABC-2 type transporter [PF19055.2, score=43.6]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=31.5]; RecF/RecN/SMC N terminal domain [PF02463.21, score=23.9]; AAA domain [PF13476.8, score=20.9]} {Human: ENSG00000118777, ABCG2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=541, Expect=0.0]} {Mouse: ENSMUSG00000029802, Abcg2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=546, Expect=0.0]} {Dmel: FBgn0003996, w, white, [Score=257, Expect=4e-74]} {Celegans: WBGene00012925, wht-8, WHiTe (Drosophila) related ABC transporter, [RH, Score=259, Expect=1e-75]} {Smed: dd_Smed_v6_4225_0_2, dd_Smed_v6_4225_0_2, [RH, Score=689, Expect=0.0]} {RNA1509_2851} {RNA1310_949.2} {RNA815_1895} |
52. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 1.903 | - | - | - | 0.965 | 0.938 | - | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
53. | MligTC455_43509 | 1526 | 31.78 | Mlig455_024779, Mlig455_066104, Mlig455_068669 | Neo: - Age: Down-Up-Up |
ACSL1 | 1.897 | - | - | - | - | 0.937 | 0.960 | Mlig455_024779 {REF} {Length: 2596} {Pfam: AMP-binding enzyme [PF00501.30, score=343.5]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.4]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=534, Expect=0.0]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=518, Expect=1e-175]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=514, Expect=2e-174]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=515, Expect=9e-175]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=513, Expect=6e-174]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=509, Expect=3e-172]} {Dmel: FBgn0036821, CG3961, [RH, Score=552, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=4e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=427, Expect=5e-141]} {RNA1509_51374} {RNA1310_7356.1} {RNA815_5550.1} Mlig455_066104 {REF} {Length: 2816} {Pfam: AMP-binding enzyme [PF00501.30, score=343.8]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.5]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=531, Expect=1e-180]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=516, Expect=3e-175]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=513, Expect=1e-173]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=512, Expect=2e-173]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=511, Expect=4e-173]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=506, Expect=5e-171]} {Dmel: FBgn0036821, CG3961, [RH, Score=551, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=6e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=424, Expect=7e-140]} {RNA1509_21029, RNA1509_51374} {RNA1310_7356.1, RNA1509_21029, RNA1509_51374} {RNA1509_21029, RNA1509_51374, RNA815_5550.1} Mlig455_068669 {REF} {Length: 2627} {Pfam: AMP-binding enzyme [PF00501.30, score=343.5]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.4]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=534, Expect=0.0]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=518, Expect=1e-175]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=514, Expect=2e-174]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=515, Expect=9e-175]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=513, Expect=6e-174]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=509, Expect=3e-172]} {Dmel: FBgn0036821, CG3961, [RH, Score=552, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=4e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=427, Expect=5e-141]} {RNA1509_51374} {RNA1310_7356.1} {RNA815_5550.1} |
54. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
1.852 | - | - | - | 0.897 | 0.955 | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
55. | MligTC455_48603 | 1006 | 20.95 | Mlig455_058556 | Neo: - Age: - Region-enriched R2: 1.380/0.01205 Regeneration-downregulated BL: -2.368 Regeneration-depleted BL: -2.368 |
CALM2 | 1.839 | - | - | - | 0.884 | 0.955 | - | Mlig455_058556 {REF} {Length: 2727} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=101.0]; EF hand [PF00036.34, score=97.2]; EF-hand domain pair [PF13833.8, score=81.7]; EF-hand domain [PF13405.8, score=78.5]; EF hand [PF13202.8, score=71.6]; EF-hand domain [PF14658.8, score=41.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.3]; Dockerin type I domain [PF00404.20, score=25.5]; SurA N-terminal domain [PF13624.8, score=19.1]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=132, Expect=1e-37]; ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=5e-37]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=3e-37]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=135, Expect=8e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=3e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=3e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=127, Expect=3e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=127, Expect=2e-36]} {Smed: dd_Smed_v6_12048_0_2, dd_Smed_v6_12048_0_2, [RH, Score=163, Expect=8e-49]} {RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1310_6210.2, RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1509_36324, RNA1509_52694, RNA1509_5720, RNA815_4293.1} |
56. | MligTC455_35411 | 583 | 12.15 | Mlig455_064235 | Neo: - Age: - |
PPP3CA | 1.819 | - | - | - | 0.861 | 0.958 | - | Mlig455_064235 {REF} {Length: 3595} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=156, Expect=8e-46]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=149, Expect=4e-43]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=158, Expect=1e-46]} {Dmel: FBgn0011826, Pp2B-14D, Protein phosphatase 2B at 14D, [Score=159, Expect=1e-46]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=115, Expect=1e-30]} {Smed: dd_Smed_v6_5669_1_2, dd_Smed_v6_5669_1_2, [Score=155, Expect=7e-49]} {RNA1509_42566} {RNA1310_30586} {RNA815_21103.2} |
57. | MligTC455_44381 | 50 | 1.04 | Mlig455_034187 | Neo: - Age: - |
1.8 | - | - | - | 0.968 | - | 0.832 | Mlig455_034187 {REF} {Length: 1133} {Pfam: WSC domain [PF01822.21, score=41.3]} {RNA1310_44307} {RNA815_33128} | |
58. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
1.796 | - | - | - | 0.962 | - | 0.834 | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
59. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
1.785 | - | - | - | 0.951 | - | 0.834 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
60. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.772 | - | - | - | 0.956 | 0.816 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
61. | MligTC455_25112 | 611 | 12.74 | Mlig455_020700 | Neo: - Age: Down-Down-Up Region-enriched R7: 1.981/0.01296 |
1.769 | - | - | - | - | 0.950 | 0.819 | Mlig455_020700 {REF} {Length: 831} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.6, Expect=8e-07]} {RNA1509_27832, RNA1509_36958} {RNA1310_50245, RNA1509_27832, RNA1509_36958} {RNA1509_27832, RNA1509_36958, RNA815_48543} | |
62. | MligTC455_18995 | 286 | 5.95 | Mlig455_032923 | Neo: - Age: - Region-specific R2: 4.016 Region-enriched R2: 3.125/0.00121 |
1.765 | - | - | - | - | 0.797 | 0.968 | Mlig455_032923 {REF} {Length: 1576} {Pfam: Transposase DDE domain [PF01609.23, score=18.9]} {RNA1509_39626} {RNA1310_29809, RNA1509_39626} {RNA1509_39626, RNA815_13636} | |
63. | MligTC455_14039 | 24 | 0.5 | Mlig455_045412 | Neo: - Age: - |
ANGPTL3 | 1.761 | - | - | - | 0.962 | 0.799 | - | Mlig455_045412 {REF} {Length: 1491} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=55.0]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=48.9, Expect=1e-05]} {Dmel: FBgn0031804, CG9500, [Score=63.9, Expect=3e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=58.2, Expect=4e-09]} {RNA1509_53291} {RNA1310_91324} {RNA815_10579.1} |
64. | MligTC455_44800 | 403 | 8.4 | Mlig455_013948, Mlig455_039343 | Neo: - Age: Down-Down-Up Region-enriched R8: 3.937/0.01062 Regeneration-downregulated BL: -8.303 Regeneration-depleted BL: -8.303 |
1.744 | - | - | - | 0.788 | - | 0.956 | Mlig455_013948 {REF} {Length: 595} {RNA1509_58184} {RNA1310_30957} {RNA815_17521} Mlig455_039343 {REF} {Length: 595} {RNA1509_58184} {RNA1310_30957, RNA1509_58184} {RNA1509_58184, RNA815_17521} |
|
65. | MligTC455_05969 | 143 | 2.98 | Mlig455_008036, Mlig455_008076 | Neo: - Age: Up-Down-Up |
CHRM3 | 1.73 | - | - | - | 0.955 | 0.775 | - | Mlig455_008036 {REF} {Length: 4356} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=235.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=49.3]; Olfactory receptor [PF13853.8, score=29.1]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [Score=252, Expect=3e-75]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=248, Expect=3e-74]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=216, Expect=9e-61]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=246, Expect=2e-73]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=243, Expect=3e-73]} {RNA1509_25623} {RNA1310_4787.1} {RNA815_38888} Mlig455_008076 {REF} {Length: 6010} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=260.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=48.6]; Olfactory receptor [PF13853.8, score=28.2]} {Human: ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [RH, Score=306, Expect=1e-95]} {Mouse: ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [RH, Score=302, Expect=3e-94]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [RH, Score=215, Expect=4e-60]} {Celegans: WBGene00001519, gar-3, Muscarinic acetylcholine receptor gar-3, [RH, Score=307, Expect=2e-96]} {Smed: dd_Smed_v6_20043_0_1, dd_Smed_v6_20043_0_1, [RH, Score=303, Expect=1e-95]} {RNA1509_25623} {RNA1310_4787.1, RNA1509_25623} {RNA1509_25623, RNA815_17017} |
66. | MligTC455_26241 | 3854 | 80.28 | Mlig455_035817 | Neo: - Age: logFC(26M/2M)=-0.749 Region-specific R2: 4.185 Region-enriched R2: 2.996/0.00000 |
PPIB | 1.713 | 0.960 | - | - | 0.753 | - | - | Mlig455_035817 {REF} {Length: 1098} {Pfam: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD [PF00160.23, score=143.1]} {Human: ENSG00000166794, PPIB, peptidylprolyl isomerase B, [Score=179, Expect=4e-56]; ENSG00000168938, PPIC, peptidylprolyl isomerase C, [Score=172, Expect=3e-53]} {Mouse: ENSMUSG00000032383, Ppib, peptidylprolyl isomerase B, [Score=178, Expect=9e-56]} {Dmel: FBgn0034753, CG2852, [Score=152, Expect=6e-46]} {Celegans: WBGene00000882, cyn-6, Peptidyl-prolyl cis-trans isomerase 6, [Score=163, Expect=2e-50]} {Smed: dd_Smed_v6_348_0_1, dd_Smed_v6_348_0_1, [RH, Score=289, Expect=7e-100]} {RNA1509_2163} {RNA1310_10180} {RNA815_2338.1} |
67. | MligTC455_20440 | 7716 | 160.76 | Mlig455_034502 | Neo: - |
TSPAN16 | 1.705 | - | - | - | 0.743 | - | 0.962 | Mlig455_034502 {REF} {Length: 1176} {Pfam: Tetraspanin family [PF00335.22, score=77.6]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=49.3, Expect=2e-06]} {Mouse: ENSMUSG00000067377, Tspan6, tetraspanin 6, [Score=48.1, Expect=4e-06]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=67.0, Expect=1e-12]} {Smed: dd_Smed_v6_3175_0_1, dd_Smed_v6_3175_0_1, [RH, Score=105, Expect=2e-26]} {RNA1509_1984, RNA1509_52808} {RNA1310_20011, RNA1509_52808} {RNA1509_52808, RNA815_7057.1} |
68. | MligTC455_20441 | 7966 | 165.95 | Mlig455_066269 | Neo: - Age: logFC(26M/2M)=-0.347 Regeneration-downregulated BL: -1.038 Regeneration-depleted BL: -1.038 |
TSPAN16 | 1.705 | - | - | - | 0.740 | - | 0.965 | Mlig455_066269 {REF} {Length: 2526} {Pfam: Tetraspanin family [PF00335.22, score=77.2]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=49.3, Expect=2e-06]} {Mouse: ENSMUSG00000067377, Tspan6, tetraspanin 6, [Score=48.1, Expect=4e-06]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_3175_0_1, dd_Smed_v6_3175_0_1, [RH, Score=105, Expect=2e-26]} {RNA1509_1984} {RNA1310_20011, RNA1509_1984} {RNA1509_1984, RNA815_7057.1} |
69. | MligTC455_43016 | 699 | 14.57 | Mlig455_057375, Mlig455_057397, Mlig455_059560 | Neo: - Age: - Region-enriched R8: 2.056/0.01340 |
CFAP97D1 | 1.689 | 0.729 | - | - | - | - | 0.960 | Mlig455_057375 {REF} {Length: 1827} {Pfam: Hemingway/CFA97 [PF13879.8, score=80.6]} {Human: ENSG00000231256, CFAP97D1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=2e-20]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [RH, Score=87.4, Expect=4e-21]; ENSMUSG00000010841, Cfap97d1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=1e-20]} {Dmel: FBgn0039408, CG14551, [RH, Score=56.2, Expect=1e-09]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=190, Expect=7e-61]} {RNA1509_33407} {RNA1310_34014.1, RNA1509_33407} {RNA1509_33407, RNA815_18616} Mlig455_057397 {REF} {Length: 1823} {Pfam: Hemingway/CFA97 [PF13879.8, score=80.6]} {Human: ENSG00000231256, CFAP97D1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=2e-20]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [RH, Score=87.4, Expect=4e-21]; ENSMUSG00000010841, Cfap97d1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=1e-20]} {Dmel: FBgn0039408, CG14551, [RH, Score=56.2, Expect=1e-09]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=190, Expect=7e-61]} {RNA1509_33407} {RNA1310_34014.1} {RNA815_18616} Mlig455_059560 {REF} {Length: 2107} {Pfam: Hemingway/CFA97 [PF13879.8, score=80.6]} {Human: ENSG00000231256, CFAP97D1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=2e-20]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [RH, Score=87.4, Expect=4e-21]; ENSMUSG00000010841, Cfap97d1, CFAP97 domain containing 1, [RH, Score=85.9, Expect=1e-20]} {Dmel: FBgn0039408, CG14551, [RH, Score=56.2, Expect=1e-09]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=190, Expect=7e-61]} {RNA1509_33407} {RNA1310_34014.1} {RNA815_18616} |
70. | MligTC455_20442 | 14887 | 310.15 | Mlig455_023972, Mlig455_066251 | Neo: - Age: Down-Up-Up |
TSPAN16 | 1.685 | - | - | - | 0.725 | - | 0.960 | Mlig455_023972 {REF} {Length: 2924} {Pfam: Tetraspanin family [PF00335.22, score=77.6]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=49.3, Expect=2e-06]} {Mouse: ENSMUSG00000067377, Tspan6, tetraspanin 6, [Score=48.1, Expect=4e-06]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=67.0, Expect=1e-12]} {Smed: dd_Smed_v6_3175_0_1, dd_Smed_v6_3175_0_1, [RH, Score=105, Expect=2e-26]} {RNA1509_1984} {RNA1310_20011} {RNA815_7057.1} Mlig455_066251 {REF} {Length: 2553} {Pfam: Tetraspanin family [PF00335.22, score=77.6]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=49.3, Expect=2e-06]} {Mouse: ENSMUSG00000067377, Tspan6, tetraspanin 6, [Score=48.1, Expect=4e-06]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=67.0, Expect=1e-12]} {Smed: dd_Smed_v6_3175_0_1, dd_Smed_v6_3175_0_1, [RH, Score=105, Expect=2e-26]} {RNA1509_18769, RNA1509_1984, RNA1509_20386} {RNA1310_20011, RNA1509_18769, RNA1509_20386} {RNA1509_18769, RNA1509_20386, RNA815_7057.1} |
71. | MligTC455_41608 | 65 | 1.36 | Mlig455_039948 | Neo: - Age: Down-Up-Down |
1.664 | - | - | - | 0.950 | - | 0.714 | Mlig455_039948 {REF} {Length: 4005} {RNA1310_25006} {RNA815_53385} | |
72. | MligTC455_14477 | 676 | 14.08 | Mlig455_030081 | Neo: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_030081 {REF} {Length: 1773} {RNA1509_4043} {RNA1310_3308.1, RNA1509_4043} {RNA1509_4043, RNA815_1039.1} | |
73. | MligTC455_07851 | 152 | 3.16 | Mlig455_000950 | Neo: - Age: - Region-enriched R4: 5.566/0.00142 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_000950 {REF} {Length: 404} {NoTransDecoderORF} | |
74. | MligTC455_40954 | 333 | 6.93 | Mlig455_042529 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_042529 {REF} {Length: 3005} {TRANSSPLICED} {RNA1509_39633} {RNA1310_7757.1} {RNA815_15362} | |
75. | MligTC455_33807 | 5328 | 111 | Mlig455_009549 | Neo: - |
MOXD1 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_009549 {REF} {Length: 2314} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=92.6]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.9]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=120, Expect=4e-28]; ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=117, Expect=6e-27]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=135, Expect=4e-33]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=127, Expect=1e-30]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=137, Expect=3e-34]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=117, Expect=1e-28]} {RNA1509_127, RNA1509_16513, RNA1509_19891, RNA1509_42226} {RNA1310_10830.1, RNA1509_127, RNA1509_16513, RNA1509_19891, RNA1509_42226} {RNA1509_127, RNA1509_16513, RNA1509_19891, RNA1509_42226, RNA815_4383.2} |
76. | MligTC455_17002 | 37 | 0.76 | Mlig455_011001 | Neo: - Age: logFC(26M/2M)=-1.400 |
P2RX2 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_011001 {REF} {Length: 3286} {Pfam: ATP P2X receptor [PF00864.21, score=289.2]} {Human: ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=207, Expect=3e-60]; ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=201, Expect=5e-59]} {Mouse: ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=202, Expect=9e-59]; ENSMUSG00000022758, P2rx6, purinergic receptor P2X, ligand-gated ion channel, 6, [Score=192, Expect=8e-56]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=270, Expect=2e-84]} {RNA1509_50956} {RNA1310_31414} {RNA815_43099} |
77. | MligTC455_34952 | 124 | 2.59 | Mlig455_012890 | Neo: - Age: Up-Down-Down Region-enriched R7: 3.857/0.02491 |
ANGPTL7 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_012890 {REF} {Length: 1624} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=123.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=102, Expect=1e-24]; ENSG00000120332, TNN, tenascin N, [Score=101, Expect=3e-23]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=98.2, Expect=2e-22]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=100, Expect=4e-24]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.4, Expect=4e-22]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=97.1, Expect=2e-22]} {Dmel: FBgn0034160, CG5550, [Score=107, Expect=2e-27]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=108, Expect=2e-26]} {RNA1509_54507} {RNA1310_26965} {RNA815_12335} |
78. | MligTC455_35985 | 177 | 3.68 | Mlig455_008831, Mlig455_008934 | Neo: - Age: - |
LIN28B | 0.955 | - | - | - | 0.955 | - | - | Mlig455_008831 {REF} {Length: 3696} {Pfam: 'Cold-shock' DNA-binding domain [PF00313.24, score=85.8]; Ribonuclease B OB domain [PF08206.13, score=22.3]} {Human: ENSG00000187772, LIN28B, lin-28 homolog B, [Score=119, Expect=3e-30]; ENSG00000131914, LIN28A, lin-28 homolog A, [Score=116, Expect=7e-30]} {Mouse: ENSMUSG00000050966, Lin28a, lin-28 homolog A (C. elegans), [Score=117, Expect=2e-30]} {Dmel: FBgn0035626, lin-28, [Score=140, Expect=1e-39]} {Celegans: WBGene00003014, lin-28, [Score=91.7, Expect=2e-21]} {Smed: dd_Smed_v6_17304_0_1, dd_Smed_v6_17304_0_1, [Score=184, Expect=6e-57]} {RNA1509_59534} {RNA1310_22733.1} {RNA815_24376} Mlig455_008934 {REF} {Length: 3189} {Pfam: 'Cold-shock' DNA-binding domain [PF00313.24, score=87.7]; Ribonuclease B OB domain [PF08206.13, score=23.9]; Zinc knuckle [PF00098.25, score=23.3]} {Human: ENSG00000187772, LIN28B, lin-28 homolog B, [RH, Score=132, Expect=6e-38]; ENSG00000131914, LIN28A, lin-28 homolog A, [RH, Score=130, Expect=9e-38]} {Mouse: ENSMUSG00000050966, Lin28a, lin-28 homolog A (C. elegans), [RH, Score=131, Expect=2e-38]} {Dmel: FBgn0035626, lin-28, [RH, Score=155, Expect=2e-48]} {Celegans: WBGene00003014, lin-28, [Score=103, Expect=4e-28]} {Smed: dd_Smed_v6_17304_0_1, dd_Smed_v6_17304_0_1, [RH, Score=201, Expect=1e-66]} {RNA1509_59534} {RNA1310_22733.1} {RNA815_24376} |
79. | MligTC455_17958 | 490 | 10.21 | Mlig455_068231 | Neo: - Age: logFC(26M/2M)=-0.406 |
CCDC83 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_068231 {REF} {Length: 2825} {Pfam: Domain of unknown function (DUF4618) [PF15397.8, score=19.3]} {Human: ENSG00000150676, CCDC83, coiled-coil domain containing 83, [RH, Score=145, Expect=2e-38]} {Mouse: ENSMUSG00000030617, Ccdc83, coiled-coil domain containing 83, [RH, Score=130, Expect=2e-33]} {Smed: dd_Smed_v6_16528_0_1, dd_Smed_v6_16528_0_1, [RH, Score=96.7, Expect=7e-22]} {RNA1509_34307, RNA1509_49481} {RNA1310_7992.1, RNA1509_34307, RNA1509_49481} {RNA1509_34307, RNA1509_49481, RNA815_3361.1} |
80. | MligTC455_33707 | 211 | 4.4 | Mlig455_018361 | Neo: - Age: - |
XRRA1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_018361 {REF} {Length: 3845} {Pfam: Leucine Rich repeats (2 copies) [PF12799.9, score=41.5]; Leucine rich repeat [PF13855.8, score=28.9]} {Human: ENSG00000166435, XRRA1, X-ray radiation resistance associated 1, [RH, Score=167, Expect=1e-45]} {Mouse: ENSMUSG00000035211, Xrra1, X-ray radiation resistance associated 1, [RH, Score=171, Expect=1e-43]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=63.9, Expect=7e-10]} {Smed: dd_Smed_v6_13519_0_1, dd_Smed_v6_13519_0_1, [RH, Score=154, Expect=3e-38]} {RNA1509_45583} {RNA1310_16743.1} {RNA815_17679} |
81. | MligTC455_33947 | 224 | 4.67 | Mlig455_049958 | Neo: - |
SLC22A13 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_049958 {REF} {Length: 4383} {Pfam: Sugar (and other) transporter [PF00083.26, score=65.2]; Major Facilitator Superfamily [PF07690.18, score=63.2]} {Human: ENSG00000172940, SLC22A13, solute carrier family 22 member 13, [Score=167, Expect=4e-44]} {Mouse: ENSMUSG00000074028, Slc22a13, solute carrier family 22 (organic cation transporter), member 13, [Score=168, Expect=1e-44]} {Dmel: FBgn0019952, Orct, Organic cation transporter, [Score=153, Expect=1e-39]} {Celegans: WBGene00003842, oct-1, Organic cation transporter 1, [Score=157, Expect=6e-41]} {Smed: dd_Smed_v6_10903_0_1, dd_Smed_v6_10903_0_1, [Score=149, Expect=9e-39]} {RNA1509_23764, RNA1509_32769, RNA1509_45293} {RNA1310_26733.1, RNA1509_23764, RNA1509_32769, RNA1509_45293} {RNA1509_23764, RNA1509_32769, RNA1509_45293, RNA815_4265} |